Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
AHCO 
Adapthealth Corp (AHCO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: AHCO (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
8 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $13.12
1 Year Target Price $13.12
| 5 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -74.46% | Avg. Invested days 20 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/28/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.25B USD | Price to earnings Ratio 17.11 | 1Y Target Price 13.12 |
Price to earnings Ratio 17.11 | 1Y Target Price 13.12 | ||
Volume (30-day avg) 8 | Beta 1.59 | 52 Weeks Range 7.11 - 11.70 | Updated Date 08/28/2025 |
52 Weeks Range 7.11 - 11.70 | Updated Date 08/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.54 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-08-05 | When - | Estimate 0.16 | Actual 0.1 |
Profitability
Profit Margin 2.49% | Operating Margin (TTM) 7.1% |
Management Effectiveness
Return on Assets (TTM) 3.7% | Return on Equity (TTM) 5.51% |
Valuation
Trailing PE 17.11 | Forward PE 11.51 | Enterprise Value 3127591434 | Price to Sales(TTM) 0.39 |
Enterprise Value 3127591434 | Price to Sales(TTM) 0.39 | ||
Enterprise Value to Revenue 0.96 | Enterprise Value to EBITDA 4.93 | Shares Outstanding 135298000 | Shares Floating 89446763 |
Shares Outstanding 135298000 | Shares Floating 89446763 | ||
Percent Insiders 8.13 | Percent Institutions 105.06 |
Upturn AI SWOT
Adapthealth Corp
Company Overview
History and Background
AdaptHealth Corp. was founded in 2012. It has grown through acquisitions to become a leading provider of home medical equipment (HME) and related services. The company focuses on providing products and services to individuals with chronic conditions.
Core Business Areas
- Home Medical Equipment (HME): Provides a range of HME products, including mobility equipment, respiratory equipment (CPAP and BiPAP machines), sleep therapy equipment, and other medical devices.
- Supplies and Services: Offers ongoing supplies and services related to the equipment, such as replacement supplies for CPAP machines and ongoing respiratory therapy services.
- Home Health Services: Provides services like medication adherence programs.
Leadership and Structure
Luke McGee is the CEO. The company has a typical corporate structure with various departments like operations, finance, sales, and marketing, reporting to the executive team.
Top Products and Market Share
Key Offerings
- Continuous Positive Airway Pressure (CPAP) Machines & Supplies: Provides CPAP machines and related supplies for sleep apnea. While market share data specifically for AdaptHealth is not readily available in a single source, the CPAP market is competitive. Competitors include ResMed (RMD), Philips Respironics (owned by Royal Philips), and Fisher & Paykel Healthcare (F&P).
- Mobility Equipment: Offers wheelchairs, scooters, and other mobility devices. Market share information is fragmented across various product types. Competitors include Invacare (IVC) and Permobil.
- Oxygen Therapy: Offers stationary oxygen concentrators, portable oxygen concentrators, and liquid oxygen systems. Competitors include Inogen (INGN) and Philips Respironics.
Market Dynamics
Industry Overview
The HME industry is driven by an aging population, increasing prevalence of chronic diseases, and advancements in medical technology. Consolidation is ongoing, with larger players acquiring smaller providers.
Positioning
AdaptHealth is a consolidator in a fragmented market, focused on scale and efficiency. Its competitive advantages include its large geographic footprint and established relationships with healthcare providers and payers.
Total Addressable Market (TAM)
The TAM for the home healthcare market is estimated to be in the hundreds of billions of dollars. AdaptHealth is positioned to capture a significant share of this market through organic growth and acquisitions.
Upturn SWOT Analysis
Strengths
- Large geographic footprint
- Established relationships with healthcare providers and payers
- Scalable business model
- Strong track record of acquisitions
Weaknesses
- High debt levels due to acquisitions
- Integration risks associated with acquisitions
- Dependence on reimbursement rates from government and private payers
- Exposure to regulatory changes
Opportunities
- Further consolidation of the HME market
- Expansion into new product and service categories
- Growth in telehealth and remote patient monitoring
- Increasing demand for home healthcare services
Threats
- Changes in reimbursement policies
- Increased competition from other HME providers
- Economic downturn
- Product recalls or safety concerns
Competitors and Market Share
Key Competitors
- RMD
- IVC
- INGN
Competitive Landscape
AdaptHealth competes on scale, geographic coverage, and service offerings. Competitors such as ResMed and Inogen have a stronger focus on specific product categories.
Major Acquisitions
AeroCare Holdings
- Year: 2021
- Acquisition Price (USD millions): 2000
- Strategic Rationale: Expanded geographic footprint and strengthened position in respiratory therapy.
Growth Trajectory and Initiatives
Historical Growth: AdaptHealth has grown rapidly through acquisitions and organic growth in recent years. It has expanded its geographic footprint and product offerings.
Future Projections: Future growth projections are dependent on market conditions and the company's ability to execute its growth strategy. Analyst estimates vary, but generally, project continued growth.
Recent Initiatives: Recent initiatives include expanding telehealth services, focusing on chronic disease management, and improving operational efficiency.
Summary
AdaptHealth is a growing company in the HME market, benefiting from industry trends and a successful acquisition strategy. Its high debt levels and dependence on reimbursement rates are potential risks. The company's focus on chronic disease management and telehealth presents opportunities for future growth. Adapthealth needs to watch out for changes in reimbursement policies and increased competition.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst estimates
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Market share data is based on estimates and may vary. Financial data should be verified through official company filings.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Adapthealth Corp
Exchange NASDAQ | Headquaters Plymouth Meeting, PA, United States | ||
IPO Launch date 2018-05-24 | CEO & Director Ms. Suzanne M. Foster M.P.H. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 10500 | Website https://adapthealth.com |
Full time employees 10500 | Website https://adapthealth.com | ||
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. The company offers sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also provides wheelchairs, hospital beds, oxygen concentrators, insulin pumps, CPAP masks and related supplies, diabetes management and wound care supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Plymouth Meeting, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.